Investigación / Grupos de investigación

Grupo  1

Inflamación y Daño Vascular en la Enfermedad Renal Crónica, Diálisis y Trasplante Renal. Fisiopatología renal

Publicaciones (313)

  • Sarmiento, E; Montanchez, J; Ezzahouri, I; Cifrian, J; Ortiz-Bautista, C; Laporta, R; Bravo, C; Salcedo, M; Rodriguez-Ferrero, ML; Gonzalez-Costello, J; Segovia, J; De Pablos, A; Mora, V; Ussetti, P; Lopez, S; Sabe, N; Gomez-Bueno, M; Sousa, I; Navas, P; Diez-Villanueva, P; Aguilar, M; Fernandez-Yunquera, A; Anaya, F; Muñoz, P; Valerio, M; Mur, A; Alarcon, A; Limay, K; Lopez-Hoyos, M; Lopez, F; Vionnet, A; Serrano, M; Carbone, J.

    Evaluation of IVIG for Prevention of Infections Occurring On-study and Treatment of Infection of Solid Organ Recipients With Secondary Antibody Deficiency: A Phase 2 Randomized Clinical Trial

    Transplantation Direct. 2026; 12(4): [doi:10.1097/TXD.0000000000001928]

  • Tejedor, M; Cussó, L; González-Nicolás, MA; San Felipe, D; Calle, D; Martín-Sánchez, B; Uzun, B; Martín-Palumbo, G; Walther, LAAS; Marco, EM; López-Gallardo, M; Lázaro, A; Desco, M.

    Recurrent intermittent hyponatremia: A new experimental model

    PLoS One. 2026; 21(2): [doi:10.1371/journal.pone.0341743]

  • Rodriguez, E; Sánchez-Cámara, L; Márquez, E; Herreros, A; Benito, S; Fernández-Lucas, M; Rubio, MV; Franquelo, R; Escaño, R; Ramos, N; Tamarit, E; Benlliure, JM; Siverio, O; Gallardo, MI; Valenzuela, MP; Davin, E; Martin-Alemany, N; Cueto, LM; Padron, MT; Tomás, MTRD; Aymat, A; Mercado, VR; Garcia, R; Cruz, SM; González, I; Medina, L; Sánchez, E; Barraca, D.

    Therapeutic Apheresis Registry of the Spanish society of Nephrology. Analysis of activity over the last five years

    NEFROLOGIA. 2026; 46(2): [doi:10.1016/j.nefro.2025.501413]

  • Terrades, NR; Benitez, PR; Gallardo, JMU; De Valdenebro, M; Salgueira, M; Andujar, AM; Martins, J; Ramos-Gali, A; Moreno, JA; de la Cuerda, C; Lloret, MJ; Menéndez, D; Acosta-Ochoa, I; Romero-González, G; Poch, E.

    Consensus document on the diagnosis and treatment of acute kidney injury

    NEFROLOGIA. 2026; 46(1): [doi:10.1016/j.nefro.2025.501360]

  • Mazon-Ruiz, J; Arroyo, D; De Cos, M; Riestra, M; Sánchez-Alvarez, E; Bores, PG; Hernández, JL; Corral, P.

    Lipid lowering therapies in chronic kidney disease: A call to action

    ATHEROSCLEROSIS. 2025; 411: [doi:10.1016/j.atherosclerosis.2025.120563]

  • Macía M; Fernández-Juárez G; Ávila AI; Espino M; Espinosa M; Fulladosa X; García-Carro C; Goicoechea M; Morales E; Quintana LF; Rojas-Rivera JE; Praga M.

    GLANCE survey: awareness and implementation of the GLOSEN recommendations for the diagnosis and treatment of lupus nephritis.

    Nefrologia. 2025; 45(9): 501354-501354 [doi:10.1016/j.nefroe.2025.501354]

  • Macía, M; Fernández-Juárez, G; Avila, AI; Espino, M; Espinosa, M; Fulladosa, X; García-Carro, C; Goicoechea, M; Morales, E; Quintana, LF; Rojas-Rivera, JE; Praga, M.

    GLANCE survey: Awareness and implementation of the GLOSEN recommendations for the diagnosis and treatment of lupus nephritis

    NEFROLOGIA. 2025; 45(9): [doi:10.1016/j.nefro.2025.501354]

  • Arnalich-Montiel, A; Barrio-Pérez, IM; Burgos-Santamaría, A; Fernández-Riveira, C; Lázaro, A; González-Nicolás, MA; Río, J; Bellón, JM; Canal, MI; Ligero, JM; Quintana-Villamandos, B.

    Influence of the type of volatile anesthetic on the development of acute kidney injury after endovascular repair of aortic aneurysm: a randomized controlled trial (DESEVAR study)

    Frontiers in Pharmacology. 2025; 16: Nº de citas: 1 [doi:10.3389/fphar.2025.1660359]

  • Martín-Ramírez, R; González-Nicolás, MA; Alvarez-Tosco, K; Machín, F; Avila, J; Morales, M; Lázaro, A; Martín-Vasallo, P.

    Cilastatin Modulates DPEP1-and IQGAP1-Associated Neuro-Glio-Vascular Inflammation in Oxaliplatin-Induced Peripheral Neurotoxicity

    Cells. 2025; 14(16): [doi:10.3390/cells14161294]

  • VALIÑO-RIVAS L; González-Nicolás MÁ; Vázquez-Ogando E; Lázaro A.

    Experimental model of unilateral ureteral obstruction reproduces key events of chronic kidney disease: From mice to humans.

    METHOD CELL BIOL. 2025; 197: 193-206 [doi:10.1016/bs.mcb.2025.07.002]

  • González-Nicolás, MA; Humanes, B; Herrero, R; Arenillas, M; López, B; Ferruelo, A; Lorente, JA; Lázaro, A.

    Cilastatin Attenuates Acute Kidney Injury and Reduces Mortality in a Rat Model of Sepsis

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(16): [doi:10.3390/ijms26167927]

  • Perez-Sáez, MJ; Melilli, E; Arias, M; Franco, A; Martinez, R; Sancho, A; Molina, M; Facundo, C; Polanco, N; López, V; Mazuecos, A; Cabello, S; García, MEG; Suárez, ML; Auyanet, I; Espi, J; Falcón, TG; Ruiz, JC; Galeano, C; Artamendi, M; Rodríguez-Ferrero, ML; Portolés, JM; Santana, MA; Martín-Moreno, PL; Arhda, N; Calvo, M; Mendiluce, A; Macía, M; Pérez-Tamajón, ML; de Teresa, J; Gascó, B; Soriano, S; Tabernero, G; de la Vara, L; Ramos, AM; Martínez, R; de Espinosa, EM; Zalve, JL; Pascual, J; Rodriguez-Mañas, L; Gutiérrez-Dalmau, A; Moreso, F.

    Frailty Prevalence and Characterization Among Kidney Transplant Candidates in Spain: A Multicenter Study

    TRANSPLANT INTERNATIONAL. 2025; 38: [doi:10.3389/ti.2025.14098]

  • Goicoechea M; García-Marina R.

    Hyperuricemia in patients with chronic kidney disease: When and what to treat?

    Nefrologia. 2025; 45(6): 501334-501334 [doi:10.1016/j.nefroe.2025.501334]

  • Goicoechea, M; Garcia-Marina, R.

    Hyperuricemia in patients with chronic kidney disease: When and what to treat?

    NEFROLOGIA. 2025; 45(6): Nº de citas: 2 [doi:10.1016/j.nefro.2025.501334]

  • López-Valverde, L; Vazquez-Mosquera, ME; Colón-Mejeras, C; Alvarez, JV; López-Pardo, BM; López, LL; Sánchez-Martínez, R; López-Mendoza, M; López-Rodríguez, M; Villacorta-Argüelles, E; Goicoechea-Diezhandino, MA; Guerrero-Márquez, FJ; Ortolano, S; Leao-Teles, E; Hermida-Ameijeiras, A; Couce, ML.

    Disrupted synaptic gene expression in Fabry disease: Findings from RNA sequencing

    NEUROBIOLOGY OF DISEASE. 2025; 209: [doi:10.1016/j.nbd.2025.106908]

  • Escamilla-Cabrera B; Montomoli M; Kislikova M; de la Espada V; Olarte-García A; García-Prieto AM; Piqueras-Sánchez S; Álvarez López Á; Rodríguez-Gayo L; Centellas-Pérez J; Villafuerte H; Barrera Baena P.

    Multicenter validation of the Kidney Failure Risk Equation (KFRE) formula in Spanish patients with advanced chronic kidney disease.

    Nefrologia. 2025; 45(5): 388-396 [doi:10.1016/j.nefroe.2025.05.003]

  • Escamilla-Cabrera, B; Montomoli, M; Kislikova, M; de la Espada, V; Olarte-García, A; García-Prieto, AM; Piqueras-Sánchez, S; López, AA; Rodríguez-Gayo, L; Centellas-Pérez, J; Villafuerte, H; Baena, PB.

    Multicenter validation of the Kidney Failure Risk Equation (KFRE) formula in Spanish patients with advanced chronic kidney disease

    NEFROLOGIA. 2025; 45(5): 388-396 [doi:10.1016/j.nefro.2025.02.004]

  • Bermejo, S; González, E; López-Revuelta, K; Ibernon, M; López, D; Martín-Gómez, A; Garcia-Osuna, R; Linares, T; Díaz, M; Martín, N; Barros, X; Marco, H; Navarro, MI; Esparza, N; Elias, S; Coloma, A; Robles, NR; Agraz, I; Poch, E; Rodas, L; Lozano, V; Fernández-Fernández, B; Hernández, E; Martínez, MI; Stanescu, RI; Moirón, JP; García-Fernández, N; Goicoechea, M; Calero, F; Bonet, J; Liaño, F; Pascual, J; Praga, M; Fulladosa, X; Soler, MJ.

    A predictive model of non-diabetic kidney disease in patients with diabetes mellitus and chronic kidney disease. A Spanish multi-center study

    NEFROLOGIA. 2025; 45(5): 360-368 [doi:10.1016/j.nefro.2024.12.007]